Condensed Consolidated Statements of Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 29, 2024		Sep. 24, 2023		Sep. 29, 2024		Sep. 24, 2023		Jun. 30, 2024		Dec. 31, 2023		Jun. 25, 2023		Dec. 25, 2022
Stockholders' equity	$ (415,619)		$ (459,898)		$ (415,619)		$ (459,898)		$ (446,140)		$ (443,616)		$ (465,479)		$ (270,664)
Transaction costs on share repurchases							2,804
Accumulated other comprehensive loss
Stockholders' equity	(6,580)	[1]	(7,916)	[2]	(6,580)	[1]	(7,916)	[2]	$ (7,358)	[1]	$ (7,803)	[1]	$ (7,289)	[2]	$ (10,135)	[2]
Net unrealized foreign currency translation loss
Stockholders' equity	(6,186)		(8,702)		(6,186)		(8,702)
Net unrealized gain (loss) on interest rate swap agreements
Stockholders' equity	(394)		(786)		(394)		(786)
Corporate Joint Venture
Net income allocable to the redeemable noncontrolling interest for joint venture arrangements	$ 43		$ 30		$ 233		$ 135

[1] At September 29, 2024, the accumulated other comprehensive loss of $6,580 was comprised of net unrealized foreign currency translation loss of $6,186 and net unrealized loss on the interest rate swap agreements of $394.

[2] At September 24, 2023, the accumulated other comprehensive loss of $7,916 was comprised of net unrealized foreign currency translation loss of $8,702 and net unrealized gain on the interest rate swap agreements of $786.